RHHBY has strengthened its pipeline with an agreement to acquire Regor's portfolio of next-generation CDK inhibitors for the treatment of breast cancer.
The U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the ...
This first-to-market launch showcases Teva’s proven strengths in complex generic formulations and enhances Teva’s strategic ...
The following is a summary of "Efficacy and safety of standard triple therapy for helicobacter pylori eradication in Latin ...
In Rwanda, Marburg virus disease has resulted in six fatalities, mainly among healthcare workers. The virus, which causes ...
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...
Bristol-Myers Squibb (BMY) stock rises as FDA approves Cobenfy as a ovel treatment for adults with the psychiatric disorder ...
FRIDAY, Sept. 27, 2024 (HealthDay News) -- An experimental monoclonal antibody treatment appears to ease the digestive ...
Pineapple contains vitamins, minerals, and other nutrients that may be beneficial for women. There is some evidence that ...
The Tijuana River has been polluted for decades, but in recent years, south San Diego residents say the smell — and their ...